105 related articles for article (PubMed ID: 28653903)
41. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
[TBL] [Abstract][Full Text] [Related]
42. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.
Li Y; Wang T; Li Y; Chen D; Yu Z; Jin L; Ni L; Yang S; Mao X; Gui Y; Lai Y
Mol Med Rep; 2016 Apr; 13(4):3326-34. PubMed ID: 26935146
[TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
44. Macrophage infiltration promotes invasiveness of breast cancer cells via activating long non-coding RNA UCA1.
Chen S; Shao C; Xu M; Ji J; Xie Y; Lei Y; Wang X
Int J Clin Exp Pathol; 2015; 8(8):9052-61. PubMed ID: 26464647
[TBL] [Abstract][Full Text] [Related]
45. MiR-199b-5p targets HER2 in breast cancer cells.
Fang C; Zhao Y; Guo B
J Cell Biochem; 2013 Jul; 114(7):1457-63. PubMed ID: 23296799
[TBL] [Abstract][Full Text] [Related]
46. Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genes.
Cuadros M; Cano C; López FJ; López-Castro R; Concha A
Pathobiology; 2013; 80(1):32-40. PubMed ID: 22832278
[TBL] [Abstract][Full Text] [Related]
47. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
48. LncRNA snaR upregulates GRB2-associated binding protein 2 and promotes proliferation of ovarian carcinoma cells.
Huang Y; Hu Y; Jin Z; Shen Z
Biochem Biophys Res Commun; 2018 Sep; 503(3):2028-2032. PubMed ID: 30093110
[TBL] [Abstract][Full Text] [Related]
49. Astrocyte elevated gene-1 induces breast cancer proliferation and invasion through upregulating HER2/neu expression.
Zhang X; Zhang N; Zhang MX
Chin Med J (Engl); 2011 Nov; 124(21):3546-50. PubMed ID: 22340175
[TBL] [Abstract][Full Text] [Related]
50. NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.
Hu P; Chu J; Wu Y; Sun L; Lv X; Zhu Y; Li J; Guo Q; Gong C; Liu B; Su S
Oncotarget; 2015 Oct; 6(32):32410-25. PubMed ID: 26378045
[TBL] [Abstract][Full Text] [Related]
51. Stroma cells: a novel target of herceptin activity.
Corsini C; Mancuso P; Paul S; Burlini A; Martinelli G; Pruneri G; Bertolini F
Clin Cancer Res; 2003 May; 9(5):1820-5. PubMed ID: 12738740
[TBL] [Abstract][Full Text] [Related]
52. A noncanonical microRNA derived from the snaR-A noncoding RNA targets a metastasis inhibitor.
Stribling D; Lei Y; Guardia CM; Li L; Fields CJ; Nowialis P; Opavsky R; Renne R; Xie M
RNA; 2021 Jun; 27(6):694-709. PubMed ID: 33795480
[TBL] [Abstract][Full Text] [Related]
53. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
[TBL] [Abstract][Full Text] [Related]
54. Genome-wide analysis of long non-coding RNA expression and function in colorectal cancer.
Jing F; Jin H; Mao Y; Li Y; Ding Y; Fan C; Chen K
Tumour Biol; 2017 May; 39(5):1010428317703650. PubMed ID: 28468580
[TBL] [Abstract][Full Text] [Related]
55. Noncoding RNA small nucleolar RNA host gene 1 promote cell proliferation in nonsmall cell lung cancer.
You J; Fang N; Gu J; Zhang Y; Li X; Zu L; Zhou Q
Indian J Cancer; 2014 Mar; 51 Suppl 3():e99-e102. PubMed ID: 25818744
[TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells.
Shi Y; Lu J; Zhou J; Tan X; He Y; Ding J; Tian Y; Wang L; Wang K
Biochem Biophys Res Commun; 2014 Apr; 446(2):448-53. PubMed ID: 24631686
[TBL] [Abstract][Full Text] [Related]
57. Up-regulation of CPNE1 Appears to Enhance Cancer Progression in HER2-positive and Luminal A Breast Cancer Cells.
Choi HY; Lee HJ; Moon KM; Moon DK; Lee S; Park H; Hong J; Park MJ; Woo DK; Yoo JC
Anticancer Res; 2022 Jul; 42(7):3445-3452. PubMed ID: 35790271
[TBL] [Abstract][Full Text] [Related]
58. Long Non-coding RNA snaR Promotes Proliferation in EGFR Wild Type Non-Small Cell Lung Cancer Cells.
Ameli Mojarad M; Ameli Mojarad M; Pourmahdian A
Int J Mol Cell Med; 2021; 10(4):258-264. PubMed ID: 35875332
[TBL] [Abstract][Full Text] [Related]
59. HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer.
Hart V; Silipo M; Satam S; Gautrey H; Kirby J; Tyson-Capper A
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2893-2912. PubMed ID: 34136934
[TBL] [Abstract][Full Text] [Related]
60. LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.
Sas-Chen A; Aure MR; Leibovich L; Carvalho S; Enuka Y; Körner C; Polycarpou-Schwarz M; Lavi S; Nevo N; Kuznetsov Y; Yuan J; Azuaje F; ; Ulitsky I; Diederichs S; Wiemann S; Yakhini Z; Kristensen VN; Børresen-Dale AL; Yarden Y
EMBO Mol Med; 2016 Sep; 8(9):1052-64. PubMed ID: 27485121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
